KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with all

Blood

Volumn 124, Issue 17, 2014, Pages 2744-2747

  Oevermann, Lena ^a   Michaelis, Sebastian U ^a   Mezger, Markus ^a   Lang, Peter ^a   Toporski, Jacek ^b   Bertaina, Alice ^c   Zecca, Marco ^d   Moretta, Lorenzo ^e   Locatelli, Franco ^c   Handgretinger, Rupert ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF PAVIA   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOIMMUNITY; ARTICLE; CD34 SELECTION; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DONOR SELECTION; EVENT FREE SURVIVAL; FEMALE; HAPLOIDENTICAL TRANSPLANTATION; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HLA MATCHING; HUMAN; HUMAN CELL; INFANT; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE RISK; RISK REDUCTION; BLOOD DONOR; CLASSIFICATION; GENETICS; GENOTYPE; KAPLAN MEIER METHOD; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TUMOR RECURRENCE;

ADOLESCENT; BLOOD DONORS; CHILD; CHILD, PRESCHOOL; DONOR SELECTION; FEMALE; GENOTYPE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; OUTCOME ASSESSMENT (HEALTH CARE); PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROPORTIONAL HAZARDS MODELS; RECEPTORS, KIR; RISK FACTORS;

EID: 84908243745     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-03-565069     Document Type: Article

References (17)

1. Moretta L, Locatelli F, Pende D, Marcenaro E, Mingari MC, Moretta A. Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. Blood. 2011;117(3):764-771.
2. Leung W. Use of NK cell activity in cure by transplant. Br J Haematol. 2011;155(1):14-29.
3. Middleton D, Gonzelez F. The extensive polymorphism of KIR genes. Immunology. 2010;129(1):8-19.
4. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295(5562):2097-2100.
5. Leung W, Iyengar R, Turner V, et al. Determinants of antileukemia effects of allogeneic NK cells. J Immunol. 2004;172(1):644-650.
6. Pfeiffer MM, Feuchtinger T, Teltschik HM, et al. Reconstitution of natural killer cell receptors influences natural killer activity and relapse rate after haploidentical transplantation of T- and B-cell depleted grafts in children. Haematologica. 2010;95(8):1381-1388.
7. Norell H, Moretta A, Silva-Santos B, Moretta L. At the Bench: Preclinical rationale for exploiting NK cells and gd T lymphocytes for the treatment of high-risk leukemias. J Leukoc Biol. 2013;94(6):1123-1139.
8. Cooley S, Weisdorf DJ, Guethlein LA, et al. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood. 2010;116(14):2411-2419.
9. Handgretinger R, Chen X, Pfeiffer M, et al. Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation. Ann N Y Acad Sci. 2007;1106:279-289.
10. Handgretinger R, Klingebiel T, Lang P, et al. Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant. 2001;27(8):777-783.
11. Stern M, Ruggeri L, Mancusi A, et al. Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. Blood. 2008;112(7):2990-2995.
12. Alves LG, Rajalingam R, Canavez F. A novel realtime PCR method for KIR genotyping. Tissue Antigens. 2009;73(2):188-191.
13. Vilches C, Castaño J, Gómez-Lozano N, Estefanía E. Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments. Tissue Antigens. 2007;70(5):415-422.
14. Scrucca L, Santucci A, Aversa F. Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant. 2010;45(9):1388-1395.
15. Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant. 2007;40(4):381-387.
16. Torelli GF, Peragine N, Raponi S, et al. Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells. Haematologica. 2014;99(7):1248-1254.
17. Michaelis SU, Mezger M, Bornhäuser M, et al. KIR haplotype B donors but not KIR-ligand mismatch result in a reduced incidence of relapse after haploidentical transplantation using reduced intensity conditioning and CD3/CD19-depleted grafts. Ann Hematol. 2014;93(9):1579-1586.